Viruses, Cytokines, Antigens, and Autoimmunity
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
New Insights to Adenovirus-Directed Innate Immunity in Respiratory Epithelial Cells
microorganisms Review New Insights to Adenovirus-Directed Innate Immunity in Respiratory Epithelial Cells Cathleen R. Carlin Department of Molecular Biology and Microbiology and the Case Comprehensive Cancer Center, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA; [email protected]; Tel.: +216-368-8939 Received: 24 June 2019; Accepted: 19 July 2019; Published: 25 July 2019 Abstract: The nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) family of transcription factors is a key component of the host innate immune response to infectious adenoviruses and adenovirus vectors. In this review, we will discuss a regulatory adenoviral protein encoded by early region 3 (E3) called E3-RIDα, which targets NFκB through subversion of novel host cell pathways. E3-RIDα down-regulates an EGF receptor signaling pathway, which overrides NFκB negative feedback control in the nucleus, and is induced by cell stress associated with viral infection and exposure to the pro-inflammatory cytokine TNF-α. E3-RIDα also modulates NFκB signaling downstream of the lipopolysaccharide receptor, Toll-like receptor 4, through formation of membrane contact sites controlling cholesterol levels in endosomes. These innate immune evasion tactics have yielded unique perspectives regarding the potential physiological functions of host cell pathways with important roles in infectious disease. Keywords: adenovirus; early region 3; innate immunity; NFκB 1. Introduction Adenoviruses have proven to be invaluable experimental tools contributing to many breakthrough discoveries, including mRNA splicing and antigen presentation to T cells [1,2]. The finding that adenovirus type 12 caused cancer in hamsters in a laboratory setting was the first example of oncogenic activity by a human virus [3]. -
Apoptosis in Viral Pathogenesis
Cell Death and Differentiation (2001) 8, 109 ± 110 ã 2001 Nature Publishing Group All rights reserved 1350-9047/01 $15.00 www.nature.com/cdd Editorial Apoptosis in viral pathogenesis JM Hardwick*,1,2,3,4,5 with an unusual deg (degradation) phenotype,1,2 leading to an understanding of how E1b 55K and E1b 19K inhibit apoptotic 1 Department of Molecular Microbiology and Immunology, Johns Hopkins cell death by distinct mechanisms. Lois Miller's laboratory University Schools of Public Health and Medicine, Baltimore, Maryland 21205, made a link to virus-induced disease when they demonstrated USA that the baculovirus-encoded caspase inhibitor P35 was 2 Department of Neurology, Johns Hopkins University Schools of Public Health required for pathogenesis.3,4 Jeurissen et al. first associated and Medicine, Baltimore, Maryland 21205, USA 3 Department of Pharmacology and Molecular Sciences, Johns Hopkins virus-induced apoptosis with disease in chickens when they University Schools of Public Health and Medicine, Baltimore, Maryland 21205, showed that chicken anemia virus infection of hatchlings USA resulted in thymocyte apoptosis.5 Cellular anti-apoptotic 4 Department of Biochemistry and Molecular Biology, Johns Hopkins University genes were then found to convert a lytic virus infection to a Schools of Public Health and Medicine, Baltimore, Maryland 21205, USA persistent infection, perhaps explaining the long-term 5 Department of Oncology, Johns Hopkins University Schools of Public Health persistence of alphaviruses in the brain.6 Early in the and Medicine, Baltimore, Maryland 21205, USA * Corresponding author: JM Hardwick, Department of Molecular Microbiology apoptosis field, a number of laboratories gathered evidence 7 and Immunology, Johns Hopkins University Schools of Public Health and for HIV-triggered apoptosis in AIDS. -
Molecular Mimicry Between Anoctamin 2 and Epstein-Barr Virus Nuclear Antigen 1 Associates with Multiple Sclerosis Risk
Molecular mimicry between Anoctamin 2 and Epstein- Barr virus nuclear antigen 1 associates with multiple sclerosis risk Katarina Tengvalla,b,1, Jesse Huanga,b, Cecilia Hellströmc, Patrick Kammerd, Martin Biströme, Burcu Ayogluf, Izaura Lima Bomfima,b,PernillaStridha,b, Julia Buttd,NicoleBrennerd,AngelikaMicheld, Karin Lundbergb,g, Leonid Padyukovb,g, Ingrid E. Lundbergb,g, Elisabet Svenungssong, Ingemar Ernbergh, Sigurgeir Olafssoni, Alexander T. Diltheyj,k, Jan Hillerta, Lars Alfredssonl,m, Peter Sundströme, Peter Nilssonc,2, Tim Waterboerd,2, Tomas Olssona,b,2, and Ingrid Kockuma,b,2 aNeuroimmunology Unit, The Karolinska Neuroimmunology & Multiple Sclerosis Centre, Department of Clinical Neuroscience, Karolinska Institute, 171 76 Stockholm, Sweden; bCentrum for Molecular Medicine, Karolinska University Hospital, 171 76 Stockholm, Sweden; cDivision of Affinity Proteomics, Department of Protein Science, SciLifeLab, KTH - Royal Institute of Technology, 171 21, Solna, Sweden; dInfections and Cancer Epidemiology, Infection, Inflammation and Cancer Research Program, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; eDepartment of Pharmacology and Clinical Neuroscience, Umeå University, 901 85 Umeå, Sweden; fDivision of Cellular and Clinical Proteomics, Department of Protein Science, SciLifeLab, KTH - Royal Institute of Technology, 171 21, Solna, Sweden; gDivision of Rheumatology, Department of Medicine Solna, Karolinska Institutet, 171 76 Stockholm, Sweden; hDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, -
030710 Molecular Mimicry in Multiple Sclerosis
The new england journal of medicine clinical implications of basic research Molecular Mimicry in Multiple Sclerosis Hartmut Wekerle, M.D., and Reinhard Hohlfeld, M.D. Most experts believe that multiple sclerosis is an senting cells expressed only the relevant HLA-DR2 autoimmune disease in which T cells recognize and restriction molecules. Normally, in HLA-DR2–pos- attack components of the axonal myelin sheath and itive persons, antigen-presenting cells (which in- other features of the central nervous system, de- clude dendritic cells, macrophages, and B cells) ex- stroying myelin and the underlying axon. Although self-reactive T cells are present in the immune sys- tem of people with multiple sclerosis, they are also found in a quiescent state in perfectly healthy peo- ple. Their pathogenic potential is realized only on acute activation, which can occur through different mechanisms. Recent work by Lang and colleagues focused on molecular mimicry, one of the presumed 1 T-cell receptor triggers of autoimmunity. Hy.2E11 Lang and coworkers investigated the antigen- specific T-cell receptor of a particular T-cell clone Epstein–Barr Myelin basic (Hy.2E11), originally isolated from the blood of a virus peptide protein peptide patient with multiple sclerosis. The clone was se- lected for its reactivity to a self antigen — the mye- lin basic protein (MBP) — but it was later found to cross-react with a peptide analogous to part of a viral antigen, the polymerase of the Epstein–Barr virus (EBV).2 The new work shows that this dual response is more complex than anticipated. The mimicry is not simply explained by the structural similarity of the two peptides, as posited by the original model of autoimmune mimicry,3 in which a foreign antigen HLA-DR2a HLA-DR2b is sufficiently similar to a self antigen to trigger an autoimmune response. -
Review Article Infectious Diseases and Autoimmunity
Review Article Infectious diseases and autoimmunity Lucia G. Delogu1, Silvia Deidda2, Giuseppe Delitala2, Roberto Manetti2 1Department of Drug Science, University of Sassari, Italy 2Department of Clinical, Experimental and Oncological Medicine, University of Sassari, Italy Abstract Introduction: Autoimmunity occurs when the immune system recognizes and attacks host tissue. In addition to genetic factors, environmental triggers (in particular viruses, bacteria and other infectious pathogens) are thought to play a major role in the development of autoimmune diseases. Methodology: We searched PubMed, Cochrane, and Scopus without time limits for relevant articles. Results: In this review, we (i) describe the ways in which an infectious agent can initiate or exacerbate autoimmunity; (ii) discuss the evidence linking certain infectious agents to autoimmune diseases in humans; and (iii) describe the animal models used to study the link between infection and autoimmunity. Conclusions: Besides genetic predisposition to autoimmunity, viral and bacterial infections are known to be involved in the initiation and promotion of autoimmune diseases. These studies suggest that pathogens can trigger autoimmunity through molecular mimicry and their adjuvant effects during initiation of disease, and can promote autoimmune responses through bystander activation or epitope spreading via inflammation and/or superantigens. Key words: viral infection; bacterial infection; autoreactive lymphocyte; molecular mimicry; bystander activation; epitope spreading; autoimmune disease J Infect Dev Ctries 2011; 5(10):679-687. (Received 03 May 2011 – Accepted 29 June 2011) Copyright © 2011 Delogu et al. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
Antigen Mimicry-Recognizing Paratope
Structural Evaluation of a Mimicry-Recognizing Paratope: Plasticity in Antigen−Antibody Interactions Manifests in Molecular Mimicry This information is current as of September 28, 2021. Suman Tapryal, Vineet Gaur, Kanwal J. Kaur and Dinakar M. Salunke J Immunol published online 3 June 2013 http://www.jimmunol.org/content/early/2013/06/01/jimmun ol.1203260 Downloaded from Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 28, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2013 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published June 3, 2013, doi:10.4049/jimmunol.1203260 The Journal of Immunology Structural Evaluation of a Mimicry-Recognizing Paratope: Plasticity in Antigen–Antibody Interactions Manifests in Molecular Mimicry Suman Tapryal,*,1 Vineet Gaur,*,1 Kanwal J. Kaur,* and Dinakar M. Salunke*,† Molecular mimicry manifests antagonistically with respect to the specificity of immune recognition. However, it often occurs because different Ags share surface topologies in terms of shape or chemical nature. -
The Role of Herpes Simplex Virus Type 1 Infection in Demyelination of the Central Nervous System
International Journal of Molecular Sciences Review The Role of Herpes Simplex Virus Type 1 Infection in Demyelination of the Central Nervous System Raquel Bello-Morales 1,2,* , Sabina Andreu 1,2 and José Antonio López-Guerrero 1,2 1 Departamento de Biología Molecular, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain; [email protected] (S.A.); [email protected] (J.A.L.-G.) 2 Centro de Biología Molecular Severo Ochoa, CSIC-UAM, Cantoblanco, 28049 Madrid, Spain * Correspondence: [email protected] Received: 30 June 2020; Accepted: 15 July 2020; Published: 16 July 2020 Abstract: Herpes simplex type 1 (HSV-1) is a neurotropic virus that infects the peripheral and central nervous systems. After primary infection in epithelial cells, HSV-1 spreads retrogradely to the peripheral nervous system (PNS), where it establishes a latent infection in the trigeminal ganglia (TG). The virus can reactivate from the latent state, traveling anterogradely along the axon and replicating in the local surrounding tissue. Occasionally, HSV-1 may spread trans-synaptically from the TG to the brainstem, from where it may disseminate to higher areas of the central nervous system (CNS). It is not completely understood how HSV-1 reaches the CNS, although the most accepted idea is retrograde transport through the trigeminal or olfactory tracts. Once in the CNS, HSV-1 may induce demyelination, either as a direct trigger or as a risk factor, modulating processes such as remyelination, regulation of endogenous retroviruses, or molecular mimicry. In this review, we describe the current knowledge about the involvement of HSV-1 in demyelination, describing the pathways used by this herpesvirus to spread throughout the CNS and discussing the data that suggest its implication in demyelinating processes. -
Butyrophilin, a Milk Protein, Modulates the Encephalitogenic T Cell Response to Myelin Oligodendrocyte Glycoprotein in Experimental Autoimmune Encephalomyelitis1
Butyrophilin, a Milk Protein, Modulates the Encephalitogenic T Cell Response to Myelin Oligodendrocyte Glycoprotein in Experimental Autoimmune Encephalomyelitis1 Andreas Stefferl,2*† Anna Schubart,2* Maria Storch,2†‡ Aminullah Amini,§ Ian Mather,§ Hans Lassmann,† and Christopher Linington3* Experimental autoimmune encephalomyelitis (EAE) induced by sensitization with myelin oligodendrocyte glycoprotein (MOG) is a T cell-dependent autoimmune disease that reproduces the inflammatory demyelinating pathology of multiple sclerosis. We report that an encephalitogenic T cell response to MOG can be either induced or alternatively suppressed as a consequence of immunological cross-reactivity, or “molecular mimicry” with the extracellular IgV-like domain of the milk protein butyrophilin (BTN). In the Dark Agouti rat, active immunization with native BTN triggers an inflammatory response in the CNS characterized by the formation of scattered meningeal and perivascular infiltrates of T cells and macrophages. We demonstrate that this pathology is mediated by a MHC class II-restricted T cell response that cross-reacts with the MOG peptide sequence 76–87, IGEGKVALRIQN (identities underlined). Conversely, molecular mimicry with BTN can be exploited to suppress disease activity in MOG-induced EAE. We demonstrate that not only is EAE mediated by the adoptive transfer of MOG74–90 T cell lines markedly ameliorated by i.v. treatment with the homologous BTN peptide, BTN74–90, but that this protective effect is also seen in actively induced disease following transmucosal -
Viruses of Respiratory Tract: an Observational Retrospective Study on Hospitalized Patients in Rome, Italy
microorganisms Article Viruses of Respiratory Tract: an Observational Retrospective Study on Hospitalized Patients in Rome, Italy 1, 2, 2 3 3 Marco Ciotti y , Massimo Maurici y, Viviana Santoro , Luigi Coppola , Loredana Sarmati , Gerardo De Carolis 4, Patrizia De Filippis 2 and Francesca Pica 5,* 1 Unit of Virology Fondazione Policlinico Tor Vergata, 00133 Rome, Italy; [email protected] 2 Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy; [email protected] (M.M.); [email protected] (V.S.); patrizia.de.fi[email protected] (P.D.F.) 3 Clinical Infectious Diseases, Fondazione Policlinico Tor Vergata, 00133 Rome, Italy; [email protected] (L.C.); [email protected] (L.S.) 4 Health Management, Fondazione Policlinico Tor Vergata, 00133 Rome, Italy; [email protected] 5 Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy * Correspondence: [email protected]; Tel.:+39-6-72596462/39-6-72596184 These authors contributed equally to this work. y Received: 4 March 2020; Accepted: 30 March 2020; Published: 1 April 2020 Abstract: Respiratory tract infections account for high morbidity and mortality around the world. Fragile patients are at high risk of developing complications such as pneumonia and may die from it. Limited information is available on the extent of the circulation of respiratory viruses in the hospital setting. Most knowledge relates to influenza viruses (FLU) but several other viruses produce flu-like illness. The study was conducted at the University Hospital Policlinico Tor Vergata, Rome, Italy. Clinical and laboratory data from hospitalized patients with respiratory tract infections during the period October 2016–March 2019 were analysed. -
Viral Pathogenesis: Influenza Knows How to Exploit Its Host
RESEARCH HIGHLIGHTS IN BRIEF BACTERIAL PATHOGENESIS More to CRISPR than adaptive immunity A new study shows that the type II CRISPR–Cas (clustered, regularly interspaced short palindromic repeats– CRISPR-associated proteins) system of the intracellular pathogen Francisella novicida downregulates the expression of an immunostimulatory bacterial lipoprotein (BLP), which increases the integrity of the cell envelope, resulting in antibiotic resistance and inflammasome evasion. Sampson et al. found that a mutant that lacked the endonuclease Cas9 was resistant to the membrane-targeting antibiotic polymyxin B, and in combination with its partner RNAs (the tracrRNA and scaRNA), Cas9 directly enhanced envelope integrity in vitro and during intracellular infection, owing, at least in part, to reduced expression of BLP. Furthermore, evasion of the AIM2– ASC inflammasome (which is activated by Toll-like receptor 2 (TLR2)) was Cas9‑dependent, and the reduced virulence of the cas9-null mutant was restored in the absence of both ASC and TLR2, which demonstrates the pivotal role of Cas9 in evading innate immunity. Further to its role in adaptive immunity, this study shows that CRISPR–Cas is an important determinant of gene expression and contributes to bacterial pathogenesis. ORIGINAL RESEARCH PAPER Sampson, T. R. et al. A CRISPR–Cas system enhances envelope integrity mediating antibiotic resistance and inflammasome evasion. Proc. Natl Acad. Sci. USA 111, 11163–11168 (2014) VIRAL PATHOGENESIS Influenza knows how to exploit its host During budding from the plasma membrane, influenza A viruses (IAVs) incorporate host proteins, but the role of these proteins in the viral life cycle is poorly understood. Berri et al. now show that the membrane protein annexin V (A5), which is upregulated during IAV infection and is incorporated into viral particles, enables escape from immune detection. -
Update on Viral Pathogenesis in BRD
*c Cambridge University Press 2009 Animal Health Research Reviews 10(2); 149–153 ISSN 1466-2523 doi:10.1017/S146625230999020X Update on viral pathogenesis in BRD John A. Ellis Department of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, 52 Campus Drive, Saskatoon, SK S7N 5B4, Canada Received 12 August 2009; Accepted 18 October 2009 Abstract Many viruses, including bovine herpesvirus-1 (BHV-1), bovine respiratory syncytial virus (BRSV), parainfluenzavirus-3 (PI3), bovine coronavirus, bovine viral diarrhea virus and bovine reovirus, have been etiologically associated with respiratory disease in cattle. This review focuses on the pathogenesis of BHV-1 and BRSV, two very different agents that primarily cause disease in the upper and lower respiratory tract, respectively. Keywords: bovine herpesvirus-1, bovine respiratory syncytial virus, immune response, immunosuppression, bovine respiratory, bovine herpesvirus, latency-related (LR), bovine respiratory disease, open reading frame (ORF-E) Bovine herpesvirus-1 (BHV-1): what are its and Chowdhury, 2008). Mechanisms of maintenance of characteristics? latency are not completely understood, but are associated with high levels of transcription of latency-related (LR) First isolated in 1956 (Madin et al., 1956), BHV-1 is a and open reading frame (ORF-E) genes. Conversely, representative of the Alphaherpesvirinae, which as a recrudesence/reactivation of latent BHV-1 and resultant group, cause similar upper respiratory tract diseases in replication in epithelia of the upper respiratory tract are a wide range of host species. These viruses are large associated with reduced expression of LR and ORF-E (135 kB), double-stranded DNA viruses composed of genes together with increased expression of other viral an icosahedral nucleocapsid, and envelope that are genes (Muylkens et al., 2007; Jones and Chowdhury, connected by a ‘tegment’. -
The SARS-Coronavirus Infection Cycle: a Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis
International Journal of Molecular Sciences Review The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis Nicholas A. Wong * and Milton H. Saier, Jr. * Department of Molecular Biology, Division of Biological Sciences, University of California at San Diego, La Jolla, CA 92093-0116, USA * Correspondence: [email protected] (N.A.W.); [email protected] (M.H.S.J.); Tel.: +1-650-763-6784 (N.A.W.); +1-858-534-4084 (M.H.S.J.) Abstract: Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a novel epidemic strain of Betacoronavirus that is responsible for the current viral pandemic, coronavirus disease 2019 (COVID- 19), a global health crisis. Other epidemic Betacoronaviruses include the 2003 SARS-CoV-1 and the 2009 Middle East Respiratory Syndrome Coronavirus (MERS-CoV), the genomes of which, particularly that of SARS-CoV-1, are similar to that of the 2019 SARS-CoV-2. In this extensive review, we document the most recent information on Coronavirus proteins, with emphasis on the membrane proteins in the Coronaviridae family. We include information on their structures, functions, and participation in pathogenesis. While the shared proteins among the different coronaviruses may vary in structure and function, they all seem to be multifunctional, a common theme interconnecting these viruses. Many transmembrane proteins encoded within the SARS-CoV-2 genome play important roles in the infection cycle while others have functions yet to be understood. We compare the various structural and nonstructural proteins within the Coronaviridae family to elucidate potential overlaps Citation: Wong, N.A.; Saier, M.H., Jr.